Mid Cap Companies with Strong Market cap: $ERIE $TECH $FNF – Wire Real Estate

Mid Cap Companies with Strong Market cap: $ERIE $TECH $FNF




Sep 2, 2020

Wire.RealEstate powered by Google



The Market Signal was created as a platform to help investors, if you own (NASDAQ:ERIE), (NASDAQ:TECH) or (NYSE:FNF) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

https://themarketsignal.com/Free-Report/NOW

(Click link above or copy, paste and hit enter in your browser for your report)

Erie Indemnity Company Introduces New Life Insurance Product

https://themarketsignal.com/Free-Report/ERIE

(Click link above or copy, paste and hit enter in your browser for your report)

Erie Indemnity Company (NASDAQ:ERIE)has one of the highest market capitalizations of $9.77billion in the mid-cap category. The company has introduced a new issue tern and whole life product, ERIExpress Life designed to simplify and expedite life insurance purchase experience. The product will help people who have no insurance cover because of the thought that the process is lengthy. ERIExpress Life is available to customers in August 2020 permitting customers to choose from various whole lie or issue term policies of between $10,000 and $500,000.Erie Family Life Insurance Company offers the ERIE(R) life insurance products but the Pennsylvania-based company does not offer services in all states. Consumers can find nearby local agents to learn more about ERIExpress Life insurance.

BIO-TECHNE Corp Partners With Leica Biosystems To Automate COVID-19 Probes

https://themarketsignal.com/Free-Report/TECH

(Click link above or copy, paste and hit enter in your browser for your report)

BIO-TECHNE Corp (NASDAQ:TECH) whose market cap is $9.75 billion is the highest amongst the mid-cap category. The company has partnered with Leica Biosystems for the automation of the RNAscope coronavirus probes on Leica's staining platform, BOND RX for research purposes only. Following the partnership, researchers can now automate COVID-19 research processes thus minimizing turnaround time and manual labor.

The R&D of Bio-Techne has developed COVID-19 probes following the releases of the genetic sequence of the virus. The company's Diagnostics and Genomic Segment President Kim Kelderman stated that the RNA probes will help researchers in gaining understanding pathogenesis of the disease. Also, the availability of the probes on the automated BOND RX platform means that discoveries will be expedited

Fidelity National Financial Chairman Sued Over Improper acquisition of FGL Holdings

https://themarketsignal.com/Free-Report/FNF

(Click link above or copy, paste and hit enter in your browser for your report)

Fidelity National Financial Inc (NYSE:FNF) whose market cap is $9.69 billion is among the highest in the mid-cap category. The company's chairman William Foley II has been taken to court by a pension fund regarding the insurer's acquisition of a $2.7billion insurance company associated with him. In February William pushed for the acquisition of FGL Holdings Inc where he was the controlling shareholder to inappropriately enrich himself.

According to the lawsuit, the transaction was not conditioned on shareholder vote and thus FNF shareholders didn't have a voice to vote about the wisdom of the acquisition. The title insurer's chief legal officer Peter Sadowski has however indicated that the complaint was without merit.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

comtex tracking

COMTEX_370546875/2703/2020-09-02T06:32:28

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.